摘要
抗生素耐药性是当今最紧迫的健康问题之一。它可能由于多种因素而产生,例如靶标修饰,药物摄取减少,代谢途径的变化和外排泵的激活。外排泵的过度表达是药物挤出的原因,使得抗生素治疗失败,因为细胞内抗生素的量不足以提供所需的治疗效果。根据其组成,底物的性质,能量来源和跨膜区域的数量,Efflux泵可以包括在五个家族中。 ABC超家族主要在革兰氏阳性菌中发现,使用ATP作为能量来源,并且只有有限数量的ABC泵赋予多药耐药性(MDR)。另一方面,大多数存在于革兰氏阳性细菌中的MFS家族和革兰氏阴性细菌特征的RND家族与抗生素抗性最相关。已经公开了来自天然或合成来源的两个家族的多种抑制剂,或者甚至是目前正在治疗其他疾病的药物。另外两个家族是SMR,它们是已知的最小的药物外排蛋白质,以及MATE家族,其泵也可以采用钠梯度作为能源。在这篇综述中,它旨在全面回顾各种来源的外排泵抑制剂类别,强调它们的结构 - 活性关系,这对于寻求新型外排泵抑制剂的药物化学家来说非常有用。
关键词: 抗菌药物,外排泵抑制剂,天然产物,合成化合物,现有药物,构效关系。
Current Medicinal Chemistry
Title:Medicinal Chemistry Updates on Bacterial Efflux Pump Modulators
Volume: 25 Issue: 42
关键词: 抗菌药物,外排泵抑制剂,天然产物,合成化合物,现有药物,构效关系。
摘要: Antibiotic resistance is one of the most pressing health issues of our days. It can arise due to a multiplicity of factors, such as target modification, decrease in the drug uptake, changes in the metabolic pathways and activation of efflux pumps. The overexpression of efflux pumps is responsible for the extrusion of drugs, making antibiotic therapy fail, as the quantity of intracellular antibiotic is not enough to provide the desired therapeutic effect.
Efflux pumps can be included in five families according to their composition, nature of substrates, energy source, and number of transmembrane spanning regions. The ABC superfamily is mainly found in Gram-positive bacteria, use ATP as an energy source, and only a limited number of ABC pumps confer multidrug resistance (MDR).
On the other hand, the MFS family, most present in Gram-positive bacteria, and the RND family, characteristic of Gram-negative bacteria, are most associated with antibiotic resistance. A wide variety of inhibitors have been disclosed for both families, from either natural or synthetic sources, or even drugs that are currently in therapy for other diseases.
The other two families are the SMR, which are the smallest drug efflux proteins known, and the MATE family, whose pumps can also resort to the sodium gradient as an energy source.
In this review, it is intended to present a comprehensive review of the classes of efflux pump inhibitors from the various sources, highlighting their structure-activity relationships, which can be useful for medicinal chemists in the pursuit of novel efflux pump inhibitors.
Export Options
About this article
Cite this article as:
Medicinal Chemistry Updates on Bacterial Efflux Pump Modulators, Current Medicinal Chemistry 2018; 25 (42) . https://dx.doi.org/10.2174/0929867325666180209142612
DOI https://dx.doi.org/10.2174/0929867325666180209142612 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the Treatment of Chronic Inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Discovery of Anticancer Agents from 2-Pyrazoline-Based Compounds
Current Medicinal Chemistry Functional Polymeric Nano/Microparticles for Surface Adsorption and Delivery of Protein and DNA Vaccines
Current Drug Delivery Advances on Cyclin-dependent Kinases (CDKs) as Novel Targets for Antiviral Drugs
Current Drug Targets - Infectious Disorders Platinum Group Antitumor Chemistry: Design and development of New Anticancer Drugs Complementary to Cisplatin
Current Medicinal Chemistry Inhibitors of Cysteine Proteases
Current Topics in Medicinal Chemistry Alternative Splice Variants of Survivin as Potential Targets in Cancer
Current Drug Discovery Technologies Charting the Bromodomain BRD4: Towards the Identification of Novel Inhibitors with Molecular Similarity and Receptor Mapping
Letters in Drug Design & Discovery Graphical Abstracts
Letters in Drug Design & Discovery <i>In Silico</i> Based Structural and Fingerprint Analysis of Structurally Diverse AT1 inhibitors
Letters in Drug Design & Discovery Pathogenesis and Immune Status in COVID-19 Pneumonia - A Minireview
Coronaviruses New Insight in LPS Antagonist
Mini-Reviews in Medicinal Chemistry Huperzine A, A Potential Therapeutic Agent for Treatment of Alzheimers Disease
Current Medicinal Chemistry GSK3 Inhibitors and Disease
Mini-Reviews in Medicinal Chemistry Pulmonary Disease in Beta-Thalassemia
Current Respiratory Medicine Reviews Novel Systemic Drugs for Cutaneous T-Cell Lymphoma
Recent Patents on Anti-Cancer Drug Discovery Development of New Therapeutic Agents for Fibrodysplasia Ossificans Progressiva.
Current Molecular Medicine Interventions Against Sarcopenia in Older Persons
Current Pharmaceutical Design Antisense Oligonucleotide Drug Design
Current Pharmaceutical Design Preface
Recent Patents on Anti-Cancer Drug Discovery Nucleoside Inhibitors of Hepatitis C Virus NS5B Polymerase: A Systematic Review
Current Drug Targets